This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1998:33 Suppl 4:25-6.

doi: 10.1159/000052260.

25-year experience in the management of invasive bladder cancer by radical cystectomy

D G Skinner¹, J P Stein, G Lieskovsky, E C Skinner, S D Boyd, A Figueroa, P Jones, R Cote, S Groshen

Affiliations

PMID: 9615206
DOI: 10.1159/000052260

Review

25-year experience in the management of invasive bladder cancer by radical cystectomy

D G Skinner et al. Eur Urol. 1998.

. 1998:33 Suppl 4:25-6.

doi: 10.1159/000052260.

Authors

D G Skinner¹, J P Stein, G Lieskovsky, E C Skinner, S D Boyd, A Figueroa, P Jones, R Cote, S Groshen

Affiliation

¹ Department of Urology, University of Southern California School of Medicine, Los Angeles 90033, USA.

PMID: 9615206
DOI: 10.1159/000052260

No abstract available

PubMed Disclaimer

Similar articles

[Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M. Słojewski M. Ann Acad Med Stetin. 2000;46:217-29. Ann Acad Med Stetin. 2000. PMID: 11712306 Polish.
Nordic prospective trials of radical cystectomy and neoadjuvant chemotherapy. The Nordic Cooperative Bladder Cancer Study Group.
Hellsten S, Rintala E, Wahlqvist R, Malmström PU. Hellsten S, et al. Eur Urol. 1998;33 Suppl 4:35-8. doi: 10.1159/000052263. Eur Urol. 1998. PMID: 9615209 Clinical Trial. No abstract available.
Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation.
May M, Helke C, Nitzke T, Vogler H, Hoschke B. May M, et al. Urol Int. 2004;72(2):103-11. doi: 10.1159/000075962. Urol Int. 2004. PMID: 14963349
Invasive T1 bladder cancer: indications and rationale for radical cystectomy.
Stein JP, Penson DF. Stein JP, et al. BJU Int. 2008 Aug;102(3):270-5. doi: 10.1111/j.1464-410X.2008.07743.x. Epub 2008 May 20. BJU Int. 2008. PMID: 18494831 Review.
[The importance of lymphadenectomy for muscle invasive transitional cell carcinoma of the human bladder - a review of the literature].
Alloussi SH, Huber S, Gakis G, Stenzl A, Schwentner C. Alloussi SH, et al. Aktuelle Urol. 2011 Mar;42(2):115-21. doi: 10.1055/s-0031-1271411. Epub 2011 Mar 24. Aktuelle Urol. 2011. PMID: 21437835 Review. German.

See all similar articles

Cited by

Surgical approach in patients with T4 bladder cancer as primary treatment: Disaster or option with improved quality of life.
Nagele U, Anastasiadis AG, Merseburger AS, Hennenlotter J, Horstmann M, Sievert KD, Stenzl A, Kuczyk MA. Nagele U, et al. Indian J Urol. 2008 Jan;24(1):95-8. doi: 10.4103/0970-1591.38610. Indian J Urol. 2008. PMID: 19468367 Free PMC article.
The rationale for radical cystectomy as primary therapy for T4 bladder cancer.
Nagele U, Anastasiadis AG, Merseburger AS, Corvin S, Hennenlotter J, Adam M, Sievert KD, Stenzl A, Kuczyk MA. Nagele U, et al. World J Urol. 2007 Aug;25(4):401-5. doi: 10.1007/s00345-007-0172-9. Epub 2007 May 25. World J Urol. 2007. PMID: 17525849
The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines.
Seraj MJ, Harding MA, Gildea JJ, Welch DR, Theodorescu D. Seraj MJ, et al. Clin Exp Metastasis. 2000;18(6):519-25. doi: 10.1023/a:1011819621859. Clin Exp Metastasis. 2000. PMID: 11592309
Upregulated MT1-MMP/TIMP-2 axis in the TSU-Pr1-B1/B2 model of metastatic progression in transitional cell carcinoma of the bladder.
Chaffer CL, Dopheide B, McCulloch DR, Lee AB, Moseley JM, Thompson EW, Williams ED. Chaffer CL, et al. Clin Exp Metastasis. 2005;22(2):115-25. doi: 10.1007/s10585-005-5141-3. Clin Exp Metastasis. 2005. PMID: 16086232
Overview of Current and Future Adjuvant Therapy for Muscle-Invasive Urothelial Carcinoma.
Nadal R, Apolo AB. Nadal R, et al. Curr Treat Options Oncol. 2018 May 28;19(7):36. doi: 10.1007/s11864-018-0551-z. Curr Treat Options Oncol. 2018. PMID: 29808294 Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information